One of the newest engineering marvels to come out of Kendall Square will be buried up to 105 feet underground where no one ...

AstraZeneca plans to invest a whopping $3. ... a new R&D centre at Kendall Square in the heart of the biopharma hub in Cambridge, Massachusetts, and a biologics manufacturing facility in Maryland.

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...

Rethinking sourcing strategies can mitigate operational risks posed by growing ideological differences. The global political ...

as well as Biogen Idec (Cambridge, MA, USA) and MedImmune, both of which had relatively slow sales growth last year, of 11% and 3%, respectively. In April this year, AstraZeneca announced that it ...

The Cambridge, Massachusetts-based biotech said in a ... Ionis Pharmaceuticals' Tegsedi and its AstraZeneca-partnered Wainua, which are used against polyneuropathy (damage to nerves) associated ...

Meanwhile, Dr. Manuel López-Figueroa and Dr. Carlos Buesa will remain on the Board, subject to a positive vote by the Shareholders’ Meeting.

Founded in Cambridge, Massachusetts in 2010 ... including significant investments from AstraZeneca and Merck. Although their vaccine candidates remained in early-stage trials, flush with cash ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

In a speech earlier this week which named AstraZeneca, the chancellor said life sciences would be key to boosting the economy. She announced plans to deliver an Oxford-Cambridge growth corridor ...